CERBA RESEARCH
LIVE

Serial Number

79338857

Owner

CERBA HEALTHCARE

Attorney

Jeffrey A. Smith

Filing Date

Jan 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CERBA RESEARCH Trademark

Serial Number: 79338857 • Registration: 7295874

CERBA RESEARCH is a trademark filed by CERBA HEALTHCARE on January 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CERBA HEALTHCARE (4 trademarks)

11-13 rue René Jacques

Entity Type: 98

Trademark Details

Filing Date

January 27, 2022

Registration Date

February 6, 2024

Published for Opposition

November 21, 2023

Goods & Services

Blood for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical use; diagnostic products for medical use, namely, medical diagnostic reagents and assays for testing of body fluids, medical diagnostic reagents; in vitro medical diagnostic testing kits comprised of reagents and assays of blood, tissue, biospecimens in the nature of serum, plasma, urine, that test for the presence of infertility, diseases, cancer; diagnostic reagents for medical or biological use sold in kit form

Blood bank services; biological sampling bank services, namely, organ and tissue bank services; biological sampling collection services being medical services; providing medical information, namely, compilation of medical reports; medical biology laboratory services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of samples taken from patients being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical, biological and veterinary analysis services for the diagnosis and treatment of humans and animals; medical, biological and veterinary information services, namely, providing information relating to treatment and management of diseases or conditions for humans and animals; medical advisory services relating to clinical trial issues; medical, biological and veterinary information retrieval service in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; medical testing for diagnostic purposes in the context of clinical trials; advisory services in the field of medical public health; provision of medical information in the field of health; providing medical information to patients, namely, provision of individual medical examination reports; carrying out disease diagnoses, namely, medical diagnosis of infertility, infectious diseases and cancer; medical and biological consultancy in the field of genetic testing, in vitro fertilization, and medical, biological and veterinary analysis services for the diagnosis and treatment of humans and animals; medical and biological analyses for treating people; veterinary and biological analyses for treating animals; DNA analyses for medical and veterinary purposes; genetic analyses for medical and veterinary use; medical and veterinary screening; medical imaging services; medical, biological and veterinary diagnostic services; services for preparing medical reports, namely, providing medical information to customers and medical professionals in the form of reports in the field of infertility, infectious diseases and cancer; medical and health assessment services with respect to DNA, genetics and genetic testing; medical testing for diagnostic or treatment purposes; x-ray examinations for medical purposes

Biological sampling collection kit for medical and diagnostic use comprised of swabs, CSF sampling tubes, holders for medical sample tubes and vials and medical specimen bags for holding body tissue samples, for testing blood, tissue, biospecimens in the nature of serum, plasma, and urine; biological sampling kit for use in clinical trials comprised of swabs, CSF sampling tubes, holders for medical sample tubes and vials and medical specimen bags for holding body tissue samples, for testing blood, tissue, biospecimens in the nature of serum, plasma, and urine; biological sampling kit for medical and biological screening use comprised of swabs, CSF sampling tubes, holders for medical sample tubes and vials and medical specimen bags for holding body tissue samples, for testing blood, tissue, biospecimens in the nature of serum, plasma, and urine; apparatus for medical use for detecting microorganisms, bacteria, yeast, viruses; apparatus for medical use in analyzing biological samples

Scientific advisory services with respect to monitoring medical diagnostic protocols; scientific advisory services with respect to calibrating scientific apparatus and instruments; scientific advisory services with respect to calibrating diagnostic apparatus and instruments; scientific advisory services with respect to developing chemical and biological reagents; laboratory services, namely, preparation of biological samples for research purposes; laboratory services, namely, preparation of biological samples for testing and analysis in research laboratories; scientific and technological services, namely, scientific research, analysis, testing in the field of genetics and medical diagnostics; scientific laboratory services; medical laboratory services; laboratory services in medical biology, namely, chemical analyses, biological analyses, bacteriological analyses, biochemical analyses, genetic analyses; medical, veterinary, pharmacological, agri-food, cosmetic research services; biological and medical research; clinical research in the field of genetics and medical diagnostics; biological, pharmacological and genetic analyses for scientific and medical research purposes; participation in conducting clinical trials, namely, scientific research in the nature of conducting clinical trials for others; providing information and data with respect to research and development in the medical, biological, pharmaceutical, agri-food, cosmetic and veterinary fields; providing information concerning the development, monitoring and results of clinical trials; engineering services in the medical field of public human health; research services in the field of human medical biology; biological and pharmaceutical research; quality control for others; designing and developing software for use as a database and medical record keeping, particularly in the medical field of human health; designing and developing databases, particularly in the medical field of human health; scientific advisory services, namely, providing advice on aspects relating to medical biology and anatomical-cytopathology examinations necessary for conducting clinical trials; scientific advisory services, namely, providing advice on clinical trial protocols; veterinary laboratory services; engineering and research services for others, namely, scientific research in the field of genetics, genetic testing and research and development of computer software; designing and developing software for accessing and viewing medical testing results and biological testing results; designing and developing databases; non-medical, ultrasound imaging services

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Nov 15, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 2, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 10, 2024 FICS
FINAL DISPOSITION PROCESSED
May 10, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 6, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 6, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 6, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Nov 21, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 21, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 1, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 1, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 17, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 17, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 17, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 17, 2023 CNEA
EXAMINER'S AMENDMENT ENTERED
Oct 16, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 16, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 16, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 16, 2023 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 16, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 27, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 27, 2023 OPNR
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 7, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 19, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 19, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 11, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 10, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
May 10, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 2, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 21, 2022 REPR